Ignite Creation Date:
2025-12-24 @ 9:09 PM
Ignite Modification Date:
2025-12-25 @ 7:00 PM
Study NCT ID:
NCT03499704
Status:
UNKNOWN
Last Update Posted:
2023-08-30
First Post:
2018-04-09
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
A Study to Evaluate the Effect of add-on Pioglitazone or Dapagliflozin in Participants With Type 2 Diabetes Mellitus Inadequately Controlled by DPP-4 Inhibitor and Metformin Therapy
Sponsor:
Celltrion Pharm, Inc.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2020-02-11
Start Date Type:
ACTUAL
Primary Completion Date:
2024-01-31
Primary Completion Date Type:
ESTIMATED
Completion Date:
2024-06-30
Completion Date Type:
ESTIMATED
First Submit Date:
2018-04-09
First Submit QC Date:
None
Study First Post Date:
2018-04-17
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2023-08-28
Last Update Post Date:
2023-08-30
Last Update Post Date Type:
ACTUAL